GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellCura ASA (FRA:C6L) » Definitions » Deferred Tax

CellCura ASA (FRA:C6L) Deferred Tax : €0.00 Mil (TTM As of Jun. 2014)


View and export this data going back to . Start your Free Trial

What is CellCura ASA Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

CellCura ASA's change in deferred tax for the three months ended in Jun. 2014 was €0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Jun. 2014 was €0.00 Mil.

CellCura ASA Deferred Tax Historical Data

The historical data trend for CellCura ASA's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellCura ASA Deferred Tax Chart

CellCura ASA Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Deferred Tax
Get a 7-Day Free Trial - - - - -

CellCura ASA Quarterly Data
Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CellCura ASA Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellCura ASA Deferred Tax Related Terms

Thank you for viewing the detailed overview of CellCura ASA's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

CellCura ASA (FRA:C6L) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellCura ASA (FRA:C6L) » Definitions » Deferred Tax
Comparable Companies
BOM:506365 WAR:PFM BOM:532041 MBVXQ GOVX XSAT:EURI B BOM:524796 HSTC GWSN BOM:524604 PRTX CTBO ARGSQ PTEO NSPX CBDC ATMS AKAOQ CAPS TSXV:PBS
Traded in Other Exchanges
N/A
Address
Unionsgata 18, Skien, NOR, 3732
Website
http://www.cellcura.com
CellCura ASA is engaged in the development of novel equipment & products for use in Assisted Reproductive Technology & Stem Cell Research globally. The company also offers software solutions used in ART lab for securing the storage & management of data.

CellCura ASA (FRA:C6L) Headlines

No Headlines